Human Islet Research Network
Menu

Project Abstracts - CBDS

Defining Islet Heterogeneity Using Single Islet Transcriptomics

Contact PI: Ivan Gerling, PhD, University of Tennessee Health Sciences Center (UC4 DK104155)

Martha Campbell-Thompson, DVM, PhD, Investigator, University of Florida
Clayton Mathews, PhD, co-Investigator, University of Florida
Mark Atkinson, PhD, co-Investigator, University of Florida
Hao Chen, PhD, co-Investigator, University of Tennessee

 

Summary of Project Abstract & Publications

Start Date: September 19, 2014
End Date:  August 31, 2018

 

Abstract

Our studies are focused on examination of single islet gene expression profiles (transcriptomes) to determine pathways critical to human beta cell death and survival.  In preliminary studies we have developed new approaches and protocols that allow laser-capture of individual islets from cryosections of human pancreas, extract the RNA, and obtain comprehensive transcriptomes.  Our proposal to the HIRN-CBDS consortium is based on using and expanding these proven protocols to gain deeper insights into islet heterogeneity and differences in gene expression patterns of individual islets from organ donors with and without diabetes as well as with or without serum autoantibodies (AAB). Based on preliminary data in islets from non-diabetic individuals with or without AAB, we hypothesize that islets develop a gene expression signature of “cellular stress” before the early stages of insulitis. A full characterization of early abnormalities in islet gene expression signatures could point to novel mechanisms of disease and new therapeutic strategies that target islet abnormalities to delay or prevent beta cell death. The use of comprehensive gene expression profiling of thousands of expressed genes will allow a very detailed look at specific pathways and processes. Our proposal has the following specific aims: Specific Aim 1 is to characterize transcriptomes of individual islets in a survey of islets from different regions of the pancreas and from organ donors with or without autoantibodies (AAB) and with or without diabetes. This will provide an unbiased survey of islet gene expression and its heterogeneity. In Specific Aim 2 we will characterize transcriptomes of individual islets selected by immunolocalization for insulin and CD3+ cells. Additionally, in Specific Aim 3 we seek to characterize transcriptomes of individual islets selected for staining patterns that mark the presence of viruses and/or metabolic stress.  In this aim we will use our newly acquired ability to conduct multiplexed immunofluorescence to define islets with novel complex phenotypes. In this aim phenotypes will be highly complex and we will stain one tissue section and then capture individual islets of interest from adjacent serial tissue sections. Mechanistic studies using isolated islets will follow from all specific aims as new pathways of cellular destruction or survival are discovered.

Publications